Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryotherapy vs 5-Fluorouracil for Actinic Keratosis
NCT06461442Phase 4Enrolling by invitation
- Sponsor
- University of California, Davis
- Start
- Jul 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluorouracil 5% cream in actinic keratosis (AK), sponsored by University of California, Davis. Primary endpoint: Partial clearance rate at 12 months. Started Jul 2024; status: enrolling by invitation.
02
Drugs
fluorouracil 5% cream
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT06461442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06461442.